20240016533. APPARATUS AND METHODS FOR REGULATING CRYOGENIC TREATMENT simplified abstract (Channel Medsystems, Inc.)

From WikiPatents
Jump to navigation Jump to search

APPARATUS AND METHODS FOR REGULATING CRYOGENIC TREATMENT

Organization Name

Channel Medsystems, Inc.

Inventor(s)

Daniel R. Burnett of San Francisco CA (US)

[[:Category:Ric Cot� of Oakland CA (US)|Ric Cot� of Oakland CA (US)]][[Category:Ric Cot� of Oakland CA (US)]]

William W. Malecki of Piedmont CA (US)

Brian M. Neil of San Francisco CA (US)

David Beaulieu of El Cerrito CA (US)

Benjamin D. Voiles of San Francisco CA (US)

Vincent Lopresti of Niwot CO (US)

APPARATUS AND METHODS FOR REGULATING CRYOGENIC TREATMENT - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240016533 titled 'APPARATUS AND METHODS FOR REGULATING CRYOGENIC TREATMENT

Simplified Explanation

The patent application describes apparatus and methods for regulating cryogenic treatments. It involves devices and methods for delivering controlled treatment using a cryoablative agent.

  • The apparatus includes an elongate probe with a distal tip and a flexible length.
  • The probe has at least one infusion lumen positioned through or along it, with one or more openings along its length.
  • The probe is enclosed by a liner that can expand.
  • An inflow reservoir or canister valve is fluidly coupled with a reservoir or canister containing the cryoablative agent.
  • A modulation control unit is fluidly coupled with the inflow reservoir or canister valve and in fluid communication with the infusion lumen.
  • A warming element is thermally coupled with the reservoir or canister.

Potential applications of this technology:

  • Cryogenic treatments in medical procedures, such as cryoablation for cancer treatment or cryotherapy for pain relief.
  • Cryogenic treatments in industrial processes, such as cryogenic machining or cryogenic preservation.

Problems solved by this technology:

  • Provides a controlled and precise delivery of cryoablative agent during cryogenic treatments.
  • Allows for targeted treatment of specific areas or tissues.
  • Enables efficient and effective cryogenic treatments.

Benefits of this technology:

  • Improved accuracy and precision in cryogenic treatments.
  • Minimizes damage to surrounding healthy tissues.
  • Enhances the effectiveness of cryoablative agents.
  • Provides a more comfortable and controlled treatment experience for patients.


Original Abstract Submitted

apparatus and methods for regulating cryogenic treatments are disclosed which comprise devices and methods for delivering controlled treatment of a cryoablative agent. in one variation, such devices may generally comprise an elongate probe having a distal tip and a flexible length, at least one infusion lumen positioned through or along the elongate probe, wherein the infusion lumen defines one or more openings along its length, and a liner expandably enclosing the probe. an inflow reservoir or canister valve may be fluidly coupled with a reservoir or canister containing the cryoablative agent and a modulation control unit may also be fluidly coupled with the inflow reservoir or canister valve and in fluid communication with the at least one infusion lumen. additionally, a warming element may also be thermally coupled with the reservoir or canister.